T1	Participants 567 628	Ten subjects (ages 35-63) with facial dyschromia and rhytides
T2	Participants 1171 1231	Ten female subjects with mild to moderate facial photodamage
T3	Participants 1370 1433	Nine of 10 patients completed the trial; 1 withdrew due to pain
